The most competitive companies in the pharmaceutical business will compete in the diabetic medicine market
The Korean pharmaceutical companies, such as CJ, Yuhan Corporation, Daewoong Pharm Co., will compete in the diabetic medicine market of SGLT-2 inhibitors.
As Astrazeneca(Forxiga), Boehringer Ingelheim(Jardiance), and Astellas(Suglat) made strategic partnerships to sell SGLT-2 inhibitors with CJ...
Fees
- Email service daily and homepage access.
- $300 per month. ($3,240 per year)
- 5 Email holders per each company.
- Anual contract base.
